assay
≥97% (HPLC)
form
solid
potency
1.4 nM Ki
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, protect from light
color
white
solubility
water: 100 mM
storage temp.
−20°C
InChI
1S/C37H50N2O10/c1-7-38-17-34(18-49-32(42)20-10-8-9-11-23(20)39-26(40)14-19(2)31(39)41)13-12-25(46-4)36-22-15-21-24(45-3)16-35(43,27(22)28(21)47-5)37(44,33(36)38)30(48-6)29(34)36/h8-11,19,21-22,24-25,27-30,33,43-44H,7,12-18H2,1-6H3/t19?,21-,22-,24+,25+,27-,28+,29-,30+,33?,34+,35-,36+,37-/m1/s1
InChI key
XLTANAWLDBYGFU-ACDIZPBGSA-N
General description
A potent antagonist highly selective for AChRs with α7 subunit (Ki = 1.4 nM for α7 subunit and >40 nM for α4β2 and α6β2 receptors). Frequently used in assessing the functional roles of AChRs with α7 subunit in brain functions and disorders (i.e. inflammatory and chronic neuropathic pain and parkinsonian neurodegeneration).
Biochem/physiol Actions
Primary Target
a7 AchR
a7 AchR
Preparation Note
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Other Notes
Suzuki, S., et al. 2013. J. Neurosci. Res.91, 462.
Freitas, K., et al. 2013. Neuropharmacol.65, 156.
Sheeja, N., et al. 2012. Hippocampus.22, 335.
Xiong, Y., et al. 2010. Pharmacol. Biochem. & Beha.95, 192.
Whiteaker, P., et al. 1999. Eur. J. Neurosci.11, 96.
Freitas, K., et al. 2013. Neuropharmacol.65, 156.
Sheeja, N., et al. 2012. Hippocampus.22, 335.
Xiong, Y., et al. 2010. Pharmacol. Biochem. & Beha.95, 192.
Whiteaker, P., et al. 1999. Eur. J. Neurosci.11, 96.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Standard Handling (A)
法规信息
新产品
此项目有